Recombinant Human BMP-7

Recombinant Human BMP-7 is widely used in research due to its potent biological activities in bone and cartilage development, tissue regeneration, and disease modeling. It is especially valuable for studies requiring a defined, consistent source of BMP-7, enabling reproducible results in cell culture, differentiation assays, and functional bioassays.

Key scientific reasons to use recombinant human BMP-7 include:

• Bone and Cartilage Regeneration: BMP-7 is a critical growth factor for osteogenesis and chondrogenesis, making it essential for in vitro studies of bone and cartilage formation, fracture repair, and tissue engineering.
• Mesenchymal Cell Differentiation: It promotes the differentiation of mesenchymal stem cells into osteoblasts and chondrocytes, supporting research in regenerative medicine and stem cell biology.
• Functional Assays: Recombinant BMP-7 is used in bioassays to study signaling pathways, cellular responses, and gene expression related to skeletal development and tissue homeostasis.
• Disease Modeling: BMP-7 has roles in inhibiting fibrosis, promoting neuroregeneration, and modulating insulin sensitivity, making it relevant for research into kidney disease, diabetes, neurodegeneration, and cancer metastasis.
• Clinical Relevance: Recombinant BMP-7 has been approved for clinical use in bone fracture repair and non-union treatment, demonstrating its translational potential and safety profile.
• Consistency and Purity: Recombinant production ensures batch-to-batch consistency, high purity, and defined activity, which are critical for experimental reproducibility and data reliability.

Best practices for using recombinant human BMP-7 in research:

• Use in serum-free or defined media for cell culture and differentiation studies to minimize variability.
• Optimize concentration and exposure time for specific cell types and experimental endpoints.
• Validate biological activity using functional assays such as alkaline phosphatase induction or collagen synthesis.
• Monitor for potential immunogenic responses in in vivo studies, as BMP-7 can induce autoantibodies in some contexts.

In summary, recombinant human BMP-7 is a versatile and reliable tool for research in skeletal biology, regenerative medicine, and disease modeling, offering well-characterized activity and broad applicability across experimental systems.

Suitability of Recombinant Human BMP-7 as ELISA Standards

Recombinant human BMP-7 can be used as a standard for ELISA quantification, but with important caveats depending on your specific application and assay design.

Appropriate Applications

Recombinant BMP-7 is well-suited for use as a calibration standard in sandwich ELISA assays designed to measure both natural and recombinant forms of the protein. The protein has been validated for this purpose, with CHO cell-expressed recombinant human BMP-7 demonstrating accurate quantitation in established assay systems. Additionally, recombinant BMP-7 can serve as a molecular standard for Western blotting and ELISA applications when studying secreted BMP-7.

Critical Limitation: Bioassay Applications

Do not use recombinant BMP-7 standards for bioassay applications. The search results explicitly note that ELISA standard recombinant proteins are not recommended for bioassay usage, as they are not tested for these applications. This is an important distinction—while recombinant protein standards work well for immunoassay-based quantification (which relies on antibody recognition), they may not accurately represent the biological activity of native protein in functional assays.

Practical Considerations

When using recombinant BMP-7 as a calibration standard, ensure that:

• Your ELISA kit is validated to recognize recombinant forms of the protein, not just endogenous BMP-7
• You prepare calibration curves using appropriate dilutions (typically ranging from 62.5 pg/mL to 4,000 pg/mL depending on the assay platform)
• You maintain proper storage conditions (typically ≤-20°C) and avoid repeated freeze-thaw cycles to preserve protein integrity

The recombinant protein will provide reliable quantification for immunoassay purposes, but verify that your specific assay platform has been validated for recombinant protein detection before proceeding.

Recombinant Human BMP-7 has been validated for a wide range of applications in published research, primarily in the fields of bone and cartilage biology, regenerative medicine, and cell signaling studies.

Key validated applications include:

• Bone regeneration and fracture healing: Extensively used for the treatment of bone fractures, especially tibial non-unions, and for enhancing bone repair and spinal fusion as an osteoinductive growth factor.
• Cartilage repair and chondrogenesis: Applied in studies of cartilage regeneration and chondrocyte differentiation, including redifferentiation assays in vitro.
• Cellular bioassays: Used to stimulate or modulate cellular responses such as osteoblast and chondrocyte differentiation, apoptosis, and insulin sensitivity in various cell types (e.g., stem cells, B cells, chondrocytes).
• Functional assays: Validated for use in functional assays to assess biological activity, such as induction of alkaline phosphatase in chondrogenic cell lines.
• ELISA and immunoassays: Used as a standard or capture reagent in ELISA and for surface plasmon resonance (SPR) studies to measure protein interactions or antibody responses.
• Western blot and immunohistochemistry: Applied as a positive control or for detection of BMP-7 in tissue and cell lysates.
• Blocking assays: Used to study inhibition of BMP-7 signaling, including the effects of autoantibodies or antagonists.
• Neuroregeneration: Investigated for its role in promoting neuronal regeneration and recovery after spinal cord injury.
• Organ development and disease models: Studied in models of kidney, liver, and prostate development, as well as in disease contexts such as fibrosis, diabetes, and cancer.

Summary Table of Validated Applications

Additional context:

• BMP-7 is widely used in both in vitro and in vivo studies, including cell culture, animal models, and clinical research.
• Its biological activity is typically validated by induction of osteogenic or chondrogenic markers, such as alkaline phosphatase or specific gene expression.
• Clinical applications are supported by regulatory approvals for certain indications, but research use extends to broader experimental models.

If you need details on protocols or specific experimental setups for any of these applications, please specify the context or assay type.

To reconstitute and prepare Recombinant Human BMP-7 for cell culture experiments, follow these steps to ensure protein stability and biological activity:

1. Centrifuge the vial briefly before opening to bring all lyophilized material to the bottom.
2. Reconstitution buffer:
   • Use sterile water containing 0.1% human serum albumin (HSA) or bovine serum albumin (BSA) as a carrier protein to prevent adsorption and loss of activity.
   • Alternatively, some protocols recommend using sterile 4 mM HCl with at least 0.1% HSA/BSA, or 10 mM acetic acid for certain formulations.
3. Protein concentration:
   • Reconstitute to a final concentration of 100–200 μg/mL. Lower concentrations may increase the risk of protein loss due to adsorption.
4. Dissolution:
   • Gently swirl or invert the vial to mix. Do not vortex or shake vigorously, as this can denature the protein.
   • Allow the solution to sit at room temperature for 15–20 minutes to ensure complete dissolution.
5. Aliquoting and storage:
   • Divide the reconstituted protein into working aliquots to avoid repeated freeze-thaw cycles, which can degrade BMP-7.
   • Store aliquots at ≤ –20°C for long-term storage. For short-term use (up to 1 week), store at 2–8°C.
6. Further dilution:
   • Make any additional dilutions for cell culture in cell culture medium or a buffered solution with low endotoxin content, ideally containing a small amount of carrier protein (e.g., 0.1% HSA/BSA) to maintain stability.

Key technical notes:

• Avoid repeated freeze-thaw cycles to preserve protein activity.
• Do not vortex during reconstitution; gentle mixing is sufficient.
• Carrier protein (HSA/BSA) is critical for preventing loss of BMP-7 due to adsorption to plasticware and maintaining biological activity.
• Sterility: Always use sterile technique and solutions to prevent contamination in cell culture applications.

Example protocol:

1. Briefly centrifuge the lyophilized BMP-7 vial.2. Add sterile water with 0.1% HSA to achieve 100 μg/mL.3. Gently mix by inversion; incubate at room temperature for 20 minutes.4. Aliquot and store at ≤ –20°C.5. For cell culture, dilute aliquots in culture medium with 0.1% HSA/BSA.

These steps are widely accepted for recombinant BMP-7 preparation for cell-based assays and organoid cultures. Adjust the final working concentration according to your experimental requirements and published dose-response data for your specific cell type.